MPO activity in PMNs from control (221.8±46.80 μmole/106cells/10 min) and SIRS patients (295.3±54.16 μmole/106cells/10 min) was however not altered significantly (Fig. 1C). This evidence concerns the gene MPO and systemic inflammatory response syndrome.